Navigation Links
Key Leadership Seminar: Maximizing Profit through Social Intelligence - What Neuroscience Tells Us
Date:3/2/2010

ctp announces key leadership event focusing on insights into the exploding field of neuroscience, what this means for leadership and how it is redefining our understanding of soft skills. This also highlights the most effective ways to motivate and generate transformation in organisations – all leading to better organisations and higher returns on human investment.

(PRWEB) March 2, 2010 -- ctp announces a key leadership event in Zurich, Switzerland. Dr Srini Pillay, Harvard Medical School, is the lead speaker at the 1/2 day seminar which will be introducing the exploding field of neuroscience and neuroleadership. Mike Pagan, UK, one of England's premiere professional speakers, will be moderating the event. Andy Habermacher, CEO of ctp, will be complementing Dr Srini Pillay by introducing the topic of neuromessaging: how to communicate more effectively to the mind.

The event will be held at the Park Hyatt, Zurich, Switzerland on March 10th 2010, between 3pm and 7pm. It will be followed by networking drinks and snacks. "This is a perfect opportunity to learn about the latest research into leadership, gain practical insights into running businesses and to socialise with other like-minded leaders." Andy Habermacher CEO of ctp noted.

Neuroscience is redefining how we think about human information processing, decision-making and motives. Maximizing Profit through Social Intelligence will approach aspects of this that are essential to leaders. Aspects of social intelligence will be shown to be of critical importance in leadership and running businesses and, rather than being a contradiction to profit motives, are essential elements.

"Social intelligence will make your business more profitable, exciting, rewarding and stimulating and more importantly: deeply satisfying for all involved. Whatever the size of your business - from the largest multinational to a small regional provider" Dr Srini Pillay noted.

Dr Srini PIllay is Assistant Clinical Professor of Psychiatry at Harvard Medical School. He has over 15 years experience in brain imaging research. He is in addition CEO of Neurobusiness Group - an international collaboration of researchers, coaches, leadership developmental experts and senior leaders. NBG’s mission is to bring research-proven strategies in social intelligence to business practices.

Mike Pagan will be moderating and complementing topics with his non-nonsense approach to practical business. "I am delighted and excited to have got such a high calibre team together for this event. It's not just the neuroscience that is fascinating: I have two great speakers who understand everything about making things practical understandable and human. This is what will make this event stand out from the standard corporate show." Andy Habermacher enthused.

###

Read the full story at http://www.prweb.com/releases/2010/03/prweb3665064.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Yakima Health Care Leader Tapped for Leadership Post at National Association
2. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
3. Patent Reform Legislation Threatens Americas Leadership in Medical Technology Innovation
4. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
5. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
6. Blue Care Network of Michigan Earns National Leadership Award for Chronic Disease Management
7. Schooner Healthcare Services, LLC Announces New Leadership Team
8. National Quality Forum Announces New Member Councils Leadership
9. Expansion and Growth Spur INSPIRIS Executive Leadership Promotions
10. Inter-American Leadership Award Bestowed Upon Chilean Chronic Disease Expert
11. amfAR Appoints New Leadership as AIDS Research Organization Extends Its Global Reach
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Key Leadership Seminar: Maximizing Profit through Social Intelligence - What Neuroscience Tells Us
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer ... East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes ... 40 speakers — representing such thought-leading companies as JP Morgan Chase, GE ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy ... industry-leading compliance software, The Guard®, has helped another long-time client pass their Department ... and properly satisfy the law. , Thanks to the help of the Compliancy ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... campaign, “Humans With Vaginas.” The goal is to ignite conversation via social media ... care products. The brand has declared September “Humans with Vaginas” month, releasing a ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... millions of older Americans at risk of price gouging for their prescription drugs, ... League (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency ...
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take on one ... better one’s life through God. “The Trials I Face to Receive God’s Grace” is ... found a love for writing. Green feels that expressing his feelings through prayer will ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... clinical grade cell and tissue hypothermic storage and ... Rice , President and CEO, will be presenting at two ... & Renshaw 19 th Annual Global Investment Conference on ... Pacific time). The conference is being held at the New ...
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/6/2017)... -- NeuroRx, a clinical stage biopharma company developing the first ... been granted Fast Track status by the US Food and ... followed by NRX-101 (D-cycloserine + lurasidone). The company will shortly ... therapy targeting patients who are admitted to Emergency Departments with ... ...
Breaking Medicine Technology: